Extended-spectrum β-lactamase genes of Escherichia coli in chicken meat and humans, the Netherlands

Emerging Infectious Diseases

Volumn 17, Issue 7, 2011, Pages 1216-1222

  Overdevest, Ilse ^a,b   Willemsen, Ina ^b   Rijnsburger, Martine ^c   Eustace, Andrew ^d   Xu, Li ^d   Hawkey, Peter ^d,e   Heck, Max ^f   Savelkoul, Paul ^c   Vandenbroucke Grauls, Christina ^c   van der Zwaluw, Kim ^f   Huijsdens, Xander ^f   Kluytmans, Jan ^a,b,c  

^a CPRLab   (Netherlands)

^b AMPHIA HOSPITAL   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^e UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^f NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM CONTAMINATION; BACTERIUM CULTURE; BACTERIUM ISOLATE; BLOOD CULTURE; CHICKEN; CONTROLLED STUDY; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE GENE; FECES ANALYSIS; FOOD CONTAMINATION; GENETIC ANALYSIS; HUMAN; MEAT; MULTILOCUS SEQUENCE TYPING; NETHERLANDS; NONHUMAN; OBSERVATIONAL STUDY; PREVALENCE; PROSPECTIVE STUDY; RECTUM;

AGED; AGED, 80 AND OVER; ANIMALS; BETA-LACTAMASES; CHICKENS; DISEASE RESERVOIRS; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FECES; FEMALE; HUMANS; MALE; MEAT; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MULTILOCUS SEQUENCE TYPING; NETHERLANDS; PREVALENCE; PROSPECTIVE STUDIES;

EID: 79959916788     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1707.110209     Document Type: Article

References (32)

1. Cosgrove SE. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis. 2006;42:S82-9. doi:10.1086/499406
2. Tumbarello M, Spanu T, Di Bidino R, Ruggeri M, Trecarichi EM, De Pascale G, et al. Costs of bloodstream infections caused by Escherichia coli infl uence of extended-spectrum-β-lactamase production and inadequate initial antibiotic therapy. Antimicrob Agents Chemother. 2010;54:4085-91. doi:10.1128/AAC.00143-10
3. Cantón R, Novais A, Valverde A, Machado E, Peixe L, Baquero F, et al. Prevalence and spread of extended-spectrum β-lactamaseproducing Enterobacteriaceae in Europe. Clin Microbiol Infect. 2008;14(Suppl 1):144-53. doi:10.1111/j.1469-0691.2007.01850.x
4. Coque TM, Baquero F, Canton R. Increasing prevalence of ESBLproducing Enterobacteriaceae in Europe. Euro Surveill. 2008;13: pii: 19044.
5. Hawkey PM, Jones AM. The changing epidemiology of resistance. J Antimicrob Chemother. 2009;64(Suppl 1):i3-10. doi:10.1093/jac/dkp256
6. Friedmann R, Raveh D, Zartzer E, Rudensky B, Broide E, Attias D, et al. Prospective evaluation of colonization with extendedspectrum β-lactamase (ESBL)-producing Enterobacteriaceae among patients at hospital admission and of subsequent colonization with ESBL-producing Enterobacteriaceae among patients during hospitalization. Infect Control Hosp Epidemiol. 2009;30:534-42. doi:10.1086/597505
7. Valverde A, Coque TM, Sánchez-Moreno MP, Rollán A, Baquero F, Cantón R. Dramatic increase in prevalence of fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain. J Clin Microbiol. 2004;42:4769-75. doi:10.1128/JCM.42.10.4769-4775.2004
8. Dubois V, De Barbeyrac B, Rogues AM, Arpin C, Coulange L, Andre C, et al. CTX-M-producing Escherichia coli in a maternity ward: a likely community importation and evidence of mother-toneonate transmission. J Antimicrob Chemother. 2010;65:1368-71. doi:10.1093/jac/dkq153
9. Xu L, Shabir S, Bodah T, McMurray C, Hardy K, Hawkey P, et al. Regional survey of CTX-M-type extended-spectrum β-lactamases among Enterobacteriaceae reveals marked heterogeneity in the distribution of the ST131 clone. J Antimicrob Chemother. 2011;66:505-11. doi:10.1093/jac/dkq482
10. Smet A, Martel A, Persoons D, Dewulf J, Heyndrickx M, Catry B, et al. Diversity of extended-spectrum β-lactamases among cloacal Escherichia coli isolates on Belgian broiler farms. Antimicrob Agents Chemother. 2008;52:1238-43. doi:10.1128/AAC.01285-07
11. Machado E, Coque TM, Cantón R, Sousa JC, Peixe L. Antibiotic resistance integrons and extended-spectrum β-lactamases among Enterobacteriaceae isolates recovered from chickens and swine in Portugal. J Antimicrob Chemother. 2008;62:296-302. doi:10.1093/jac/dkn179
12. Doi Y, Paterson DL, Egea P, Pascual A, López-Cerero L, Navarro MD, et al. Extended-spectrum and CMY-type β-lactamaseproducing Escherichia coli in clinical samples and retail meat from Pittsburgh, USA and Seville, Spain. Clin Microbiol Infect. 2010;16:33-8. doi:10.1111/j.1469-0691.2009.03001x
13. Warren RE, Ensor VM, O'Neill P, Butler V, Taylor J, Nye K, et al. Imported chicken meat as a potential source of quinolone-resistant Escherichia coli producing extended-spectrum β-lactamases in the UK. J Antimicrob Chemother. 2008;61:504-8. doi:10.1093/jac/dkm517
14. Randall LP, Clouting C, Horton RA, Coldham NG, Wu G, Clifton-Hadley FA, et al. Prevalence of Escherichia coli carrying extendedspectrum β-lactamases (CTX-M and TEM-52) from broiler chickens and turkeys in Great Britain between 2006 and 2009. J Antimicrob Chemother. 2011;66:86-95. doi:10.1093/jac/dkq396
15. Goossens H, Ferech M, Vander Stichele R, Elseviers M. Outpatient antimicrobial use in Europe and association with resistance: a crossnational database study. Lancet. 2005;365:579-87.
16. Grave K, Torren-Edo J, Mackay D. Comparison of the sales of veterinary antimicrobial agents between 10 European countries. J Antimicrob Chemother. 2010;65:2037-40. doi:10.1093/jac/dkq247
17. van Loo I, Huijsdens X, Tiemersma E, de Neeling A, van de Sande-Bruinsma N, Beaujean D, et al. Emergence of methicillin-resistant Staphylococcus aureus of animal origin in humans. Emerg Infect Dis. 2007;13:1834-9.
18. Al Naiemi N, Cohen Stuart J, Leverstein van Hall M. NVMMguideline for screening en confirmation of extended-spectrum-β-lactamases (ESBLs) in Enterobacteriaceae [in Dutch]. Tijdschrift voor Medische Microbiologie. 2008;2:23-8.
19. Xu L, Evans J, Ling T, Nye K, Hawkey P. Rapid genotyping of CTX-M extended-spectrum β-lactamases by denaturating high-performance liquid chromatography. Antimicrob Agents Chemother. 2007;51:1446-54. doi:10.1128/AAC.01088-06
20. Cohen Stuart J, Dierikx C, Al Naiemi N, Karczmarek A, Van Hoek AH, Vos P, et al. Rapid detection of TEM, SHV and CTX-M extended- spectrum β-lactamases in Enterobacteriaceae using ligationmediated amplification with microarray analysis. J Antimicrob Chemother. 2010;65:1377-81. doi:10.1093/jac/dkq146
21. Wirth T, Falush D, Lan R, Colles F, Mensa P, Wieler LH, et al. Sex and virulence in Escherichia coli: an evolutionary perspective. Mol Microbiol. 2006;60:1136-51. doi:10.1111/j.1365-2958.2006.05172.x
22. Willemsen I, Mooij M, van der Wiel M, Bogaers D, van der Bijl M, Savelkoul P, et al. Highly resistant microorganisms in a teaching hospital: the role of horizontal spread in a setting of endemicity. Infect Control Hosp Epidemiol. 2008;29:1110-7. doi:10.1086/592408
23. MARAN 2008. Monitoring of antimicrobial resistance and antibiotic usage in animals in the Netherlands in 2008 [cited 2011 Apr 14]. www.cvi.wur.nl/NR/rdonlyres/DDA15856-1179-4CAB-BAC6-28C4728ACA03/110563/MARAN_2008_definitief_corrected.pdf
24. European Antimicrobial Resistance Eurveillance System. EARSS annual report 2008 [cited 2011 Apr 14]. www.ecdc.europa.eu/en/activities/surveillance/EARS-Net/Documents/2008_EARSS_Annual_Report.pdf
25. Reddy P, Malczynski M, Obias A, Reiner S, Jin N, Huang J, et al. Screening for extended-spectrum β-lactamase-producing Enterobacteriaceae among high-risk patients and rates of subsequent bacteraemia. Clin Infect Dis. 2007;45:846-52. doi:10.1086/521260
26. Carattoli A. Resistance plasmid families in Enterobacteriaceae. Antimicrob Agents Chemother. 2009;53:2227-38. doi:10.1128/AAC.01707-08
27. DuPont HL. The growing threat of foodborne bacterial enteropathogens of animal origin. Clin Infect Dis. 2007;45:1353-61. doi:10.1086/522662
28. Johnson JR, Sannes MR, Croy C, Johnston B, Clabots C, Kuskowski MA, et al. Antimicrobial drug-resistant Escherichia coli from humans and poultry products, Minnesota and Wisconsin, 2002-2004. Emerg Infect Dis. 2007;13:838-46. doi:10.3201/eid1306.061576
29. Smet A, Rasschaert G, Martel A, Persoons D, Dewulf J, Butaye P, et al. In situ ESBL conjugation from avian to human Escherichia coli during cefotaxime administration. J Appl Microbiol. 2011;110:541-9. doi:10.1111/j.1365-2672.2010.04907.x
30. Dutil L, Irwin R, Finley R, Ng LK, Avery B, Boerlin P, et al. Ceftiofur resistance in Salmonella enterica serovar Heidelberg from chicken meat and humans, Canada. Emerg Infect Dis. 2010;16:48-4. doi:10.3201/eid1601.090729
31. Vincent C, Boerlin P, Daignault D, Dozois CM, Dutil L, Galanakis C, et al. Food reservoir for Escherichia coli causing urinary tract infections. Emerg Infect Dis. 2010;16:88-95. doi:10.3201/eid1601.091118
32. Mora A, Herrera A, Mamani R, López C, Alonso MP, Blanco JE, et al. Recent emergence of clonal group O25b:K1:H4-B2-ST131 ibeA strains among Escherichia coli poultry isolates, including CTX-M-9-producing strains, and comparison with clinical human isolates. Appl Environ Microbiol. 2010;76:6991-7. doi:10.1128/ AEM.01112-10